Key facts
- This page summarizes Leanne Kelly's Form 4 filing for GRI Bio, Inc. (GRI).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 22 Sep 2025, 16:06.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Options to purchase 29,923 shares vested in full upon the date of grant and options to purchase 13,299 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant.